Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · June 27, 2018

Half-Dose Photodynamic Therapy vs High-Density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy

Ophthalmology

 

Additional Info

Ophthalmology
Half-Dose Photodynamic Therapy Versus High-Density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy: The PLACE Trial
Ophthalmology 2018 May 15;[EPub Ahead of Print], EHC van Dijk, S Fauser, MB Breukink, R Blanco-Garavito, JMM Groenewoud, JEE Keunen, PJH Peters, G Dijkman, EH Souied, RE MacLaren, G Querques, SM Downes, CB Hoyng, CJF Boon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading